N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide

C148H178N26O12 — CID 157307971

IUPACN-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide
SMILESCc1ccc(C(=O)/N=C2\Cc3ccc(CN4CCOCC4)cc3N2C2CCC(C(=O)N3CCNCC3)CC2)cc1.Cc1ccc(C(=O)/N=C2\Cc3ccc(CN4CCOCC4)cc3N2C2CCC(C(N)=O)CC2)cc1.Cc1ccc(C(=O)/N=C2\Cc3ccc(Cn4cccn4)cc3N2C2CCC(C(=O)NC(C)C)CC2)cc1.Cc1ccc(C(=O)/N=C2\Cc3ccc(Cn4cncn4)cc3N2C2CCC(C(=O)NC(C)C)CC2)cc1.Cc1ccc(C(=O)/N=C2\Cc3ccc(Cn4cnnc4)cc3N2C2CCC(C(=O)NC(C)C)CC2)cc1
InChIInChI=1S/C32H41N5O3.C30H35N5O2.2C29H34N6O2.C28H34N4O3/c1-23-2-5-25(6-3-23)31(38)34-30-21-27-7-4-24(22-35-16-18-40-19-17-35)20-29(27)37(30)28-10-8-26(9-11-28)32(39)36-14-12-33-13-15-36;1-20(2)32-29(36)24-11-13-26(14-12-24)35-27-17-22(19-34-16-4-15-31-34)7-10-25(27)18-28(35)33-30(37)23-8-5-21(3)6-9-23;1-19(2)32-28(36)23-10-12-25(13-11-23)35-26-14-21(16-34-17-30-31-18-34)6-9-24(26)15-27(35)33-29(37)22-7-4-20(3)5-8-22;1-19(2)32-28(36)23-10-12-25(13-11-23)35-26-14-21(16-34-18-30-17-31-34)6-9-24(26)15-27(35)33-29(37)22-7-4-20(3)5-8-22;1-19-2-5-22(6-3-19)28(34)30-26-17-23-7-4-20(18-31-12-14-35-15-13-31)16-25(23)32(26)24-10-8-21(9-11-24)27(29)33/h2-7,20,26,28,33H,8-19,21-22H2,1H3;4-10,15-17,20,24,26H,11-14,18-19H2,1-3H3,(H,32,36);2*4-9,14,17-19,23,25H,10-13,15-16H2,1-3H3,(H,32,36);2-7,16,21,24H,8-15,17-18H2,1H3,(H2,29,33)/b34-30+;33-28+;2*33-27+;30-26+
InChIKeyBCSDQOIUZPTBTP-WOIJKMJFSA-N
MW2513.22 g/mol
LogP20.46
Rot. Bonds28

About N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide

N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide (PubChem CID 157307971) has the molecular formula C148H178N26O12 and a molecular weight of 2513.22 g/mol. Its IUPAC name is N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide.

Molecular Properties

Compound NameN-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide
PubChem CID157307971
Molecular FormulaC148H178N26O12
Molecular Weight2513.22 g/mol
Exact Mass2511.41
IUPAC NameN-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide
SMILESCc1ccc(C(=O)/N=C2\Cc3ccc(CN4CCOCC4)cc3N2C2CCC(C(=O)N3CCNCC3)CC2)cc1.Cc1ccc(C(=O)/N=C2\Cc3ccc(CN4CCOCC4)cc3N2C2CCC(C(N)=O)CC2)cc1.Cc1ccc(C(=O)/N=C2\Cc3ccc(Cn4cccn4)cc3N2C2CCC(C(=O)NC(C)C)CC2)cc1.Cc1ccc(C(=O)/N=C2\Cc3ccc(Cn4cncn4)cc3N2C2CCC(C(=O)NC(C)C)CC2)cc1.Cc1ccc(C(=O)/N=C2\Cc3ccc(Cn4cnnc4)cc3N2C2CCC(C(=O)NC(C)C)CC2)cc1
InChIInChI=1S/C32H41N5O3.C30H35N5O2.2C29H34N6O2.C28H34N4O3/c1-23-2-5-25(6-3-23)31(38)34-30-21-27-7-4-24(22-35-16-18-40-19-17-35)20-29(27)37(30)28-10-8-26(9-11-28)32(39)36-14-12-33-13-15-36;1-20(2)32-29(36)24-11-13-26(14-12-24)35-27-17-22(19-34-16-4-15-31-34)7-10-25(27)18-28(35)33-30(37)23-8-5-21(3)6-9-23;1-19(2)32-28(36)23-10-12-25(13-11-23)35-26-14-21(16-34-17-30-31-18-34)6-9-24(26)15-27(35)33-29(37)22-7-4-20(3)5-8-22;1-19(2)32-28(36)23-10-12-25(13-11-23)35-26-14-21(16-34-18-30-17-31-34)6-9-24(26)15-27(35)33-29(37)22-7-4-20(3)5-8-22;1-19-2-5-22(6-3-19)28(34)30-26-17-23-7-4-20(18-31-12-14-35-15-13-31)16-25(23)32(26)24-10-8-21(9-11-24)27(29)33/h2-7,20,26,28,33H,8-19,21-22H2,1H3;4-10,15-17,20,24,26H,11-14,18-19H2,1-3H3,(H,32,36);2*4-9,14,17-19,23,25H,10-13,15-16H2,1-3H3,(H,32,36);2-7,16,21,24H,8-15,17-18H2,1H3,(H2,29,33)/b34-30+;33-28+;2*33-27+;30-26+
InChIKeyBCSDQOIUZPTBTP-WOIJKMJFSA-N
XLogP20.46
TPSA430.26 Ų
H-Bond Donors5
H-Bond Acceptors23
Rotatable Bonds28
Heavy Atoms186
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002513.22
LogP ≤ 520.46
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide?
The IUPAC name of N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide (CID 157307971) is N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide.
What is the SMILES notation for N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide?
The canonical SMILES for N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide is Cc1ccc(C(=O)/N=C2\Cc3ccc(CN4CCOCC4)cc3N2C2CCC(C(=O)N3CCNCC3)CC2)cc1.Cc1ccc(C(=O)/N=C2\Cc3ccc(CN4CCOCC4)cc3N2C2CCC(C(N)=O)CC2)cc1.Cc1ccc(C(=O)/N=C2\Cc3ccc(Cn4cccn4)cc3N2C2CCC(C(=O)NC(C)C)CC2)cc1.Cc1ccc(C(=O)/N=C2\Cc3ccc(Cn4cncn4)cc3N2C2CCC(C(=O)NC(C)C)CC2)cc1.Cc1ccc(C(=O)/N=C2\Cc3ccc(Cn4cnnc4)cc3N2C2CCC(C(=O)NC(C)C)CC2)cc1.
What is the InChIKey of N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide?
The InChIKey is BCSDQOIUZPTBTP-WOIJKMJFSA-N. The full InChI is InChI=1S/C32H41N5O3.C30H35N5O2.2C29H34N6O2.C28H34N4O3/c1-23-2-5-25(6-3-23)31(38)34-30-21-27-7-4-24(22-35-16-18-40-19-17-35)20-29(27)37(30)28-10-8-26(9-11-28)32(39)36-14-12-33-13-15-36;1-20(2)32-29(36)24-11-13-26(14-12-24)35-27-17-22(19-34-16-4-15-31-34)7-10-25(27)18-28(35)33-30(37)23-8-5-21(3)6-9-23;1-19(2)32-28(36)23-10-12-25(13-11-23)35-26-14-21(16-34-17-30-31-18-34)6-9-24(26)15-27(35)33-29(37)22-7-4-20(3)5-8-22;1-19(2)32-28(36)23-10-12-25(13-11-23)35-26-14-21(16-34-18-30-17-31-34)6-9-24(26)15-27(35)33-29(37)22-7-4-20(3)5-8-22;1-19-2-5-22(6-3-19)28(34)30-26-17-23-7-4-20(18-31-12-14-35-15-13-31)16-25(23)32(26)24-10-8-21(9-11-24)27(29)33/h2-7,20,26,28,33H,8-19,21-22H2,1H3;4-10,15-17,20,24,26H,11-14,18-19H2,1-3H3,(H,32,36);2*4-9,14,17-19,23,25H,10-13,15-16H2,1-3H3,(H,32,36);2-7,16,21,24H,8-15,17-18H2,1H3,(H2,29,33)/b34-30+;33-28+;2*33-27+;30-26+.
What are the key properties of N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide?
N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide has a molecular weight of 2513.22 g/mol, XLogP of 20.46, 28 rotatable bonds, 5 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-(4-carbamoylcyclohexyl)-6-(morpholin-4-ylmethyl)-3H-indol-2-ylidene]-4-methylbenzamide;4-methyl-N-[6-(morpholin-4-ylmethyl)-1-[4-(piperazine-1-carbonyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(pyrazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-1-ylmethyl)-3H-indol-2-ylidene]benzamide;4-methyl-N-[1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-6-(1,2,4-triazol-4-ylmethyl)-3H-indol-2-ylidene]benzamide is sourced from PubChem (CID 157307971), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).